img

Global Oral Solid Dosage Medicine Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Oral Solid Dosage Medicine Market Research Report 2024

Oral drug delivery is the most convenient, high patient compliant, cost effective, and safe route of administration to treat various diseases. Oral solid dosage (OSD) form refers to a final drug product that is ingested through the mouth, dissolved in the digestive system, and delivered to the body through absorption into the bloodstream. The most common OSD forms - tablets and capsules - are efficient and cost-effective to manufacture, shelf stable and easy to administer. They are widely understood and embraced by patients worldwide. They are preferred by pharmaceutical manufacturers owing to the advantage of economy of scale.
According to Mr Accuracy reports’s new survey, global Oral Solid Dosage Medicine market is projected to reach US$ 502740 million in 2029, increasing from US$ 357150 million in 2022, with the CAGR of 5.0% during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Oral Solid Dosage Medicine market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Oral Solid Dosage Medicine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


Johnson & Johnson
Novartis
Roche
AbbVie
Merck & Co.
Bristol Myers Squibb
GlaxoSmithKline
Pfizer
Sanofi
Takeda
AstraZeneca
Bayer
Eli Lilly & Co.
Gilead Sciences
Amgen
Novo Nordisk
Teva
Boehringer Ingelheim
Biogen
Astellas
Segment by Type
Brands Drugs
Generic Drugs

Segment by Application


Hospital
Retail Pharmacy
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The Oral Solid Dosage Medicine report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Global market size, regional market size. Market Opportunities and Challenges
Chapter 3Companies’ Competition Patterns
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6 to 10Country Level Value Analysis
Chapter 11Companies' Outline
Chapter 12Market Conclusions
Chapter 13Research Methodology and Data Source

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oral Solid Dosage Medicine Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Brands Drugs
1.2.3 Generic Drugs
1.3 Market by Application
1.3.1 Global Oral Solid Dosage Medicine Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Oral Solid Dosage Medicine Market Perspective (2018-2029)
2.2 Oral Solid Dosage Medicine Growth Trends by Region
2.2.1 Global Oral Solid Dosage Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Oral Solid Dosage Medicine Historic Market Size by Region (2018-2024)
2.2.3 Oral Solid Dosage Medicine Forecasted Market Size by Region (2024-2029)
2.3 Oral Solid Dosage Medicine Market Dynamics
2.3.1 Oral Solid Dosage Medicine Industry Trends
2.3.2 Oral Solid Dosage Medicine Market Drivers
2.3.3 Oral Solid Dosage Medicine Market Challenges
2.3.4 Oral Solid Dosage Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oral Solid Dosage Medicine Players by Revenue
3.1.1 Global Top Oral Solid Dosage Medicine Players by Revenue (2018-2024)
3.1.2 Global Oral Solid Dosage Medicine Revenue Market Share by Players (2018-2024)
3.2 Global Oral Solid Dosage Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Oral Solid Dosage Medicine Revenue
3.4 Global Oral Solid Dosage Medicine Market Concentration Ratio
3.4.1 Global Oral Solid Dosage Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oral Solid Dosage Medicine Revenue in 2022
3.5 Oral Solid Dosage Medicine Key Players Head office and Area Served
3.6 Key Players Oral Solid Dosage Medicine Product Solution and Service
3.7 Date of Enter into Oral Solid Dosage Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oral Solid Dosage Medicine Breakdown Data by Type
4.1 Global Oral Solid Dosage Medicine Historic Market Size by Type (2018-2024)
4.2 Global Oral Solid Dosage Medicine Forecasted Market Size by Type (2024-2029)
5 Oral Solid Dosage Medicine Breakdown Data by Application
5.1 Global Oral Solid Dosage Medicine Historic Market Size by Application (2018-2024)
5.2 Global Oral Solid Dosage Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Oral Solid Dosage Medicine Market Size (2018-2029)
6.2 North America Oral Solid Dosage Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Oral Solid Dosage Medicine Market Size by Country (2018-2024)
6.4 North America Oral Solid Dosage Medicine Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Oral Solid Dosage Medicine Market Size (2018-2029)
7.2 Europe Oral Solid Dosage Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Oral Solid Dosage Medicine Market Size by Country (2018-2024)
7.4 Europe Oral Solid Dosage Medicine Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Oral Solid Dosage Medicine Market Size (2018-2029)
8.2 Asia-Pacific Oral Solid Dosage Medicine Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Oral Solid Dosage Medicine Market Size by Region (2018-2024)
8.4 Asia-Pacific Oral Solid Dosage Medicine Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Oral Solid Dosage Medicine Market Size (2018-2029)
9.2 Latin America Oral Solid Dosage Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Oral Solid Dosage Medicine Market Size by Country (2018-2024)
9.4 Latin America Oral Solid Dosage Medicine Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oral Solid Dosage Medicine Market Size (2018-2029)
10.2 Middle East & Africa Oral Solid Dosage Medicine Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Oral Solid Dosage Medicine Market Size by Country (2018-2024)
10.4 Middle East & Africa Oral Solid Dosage Medicine Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Johnson & Johnson
11.1.1 Johnson & Johnson Company Detail
11.1.2 Johnson & Johnson Business Overview
11.1.3 Johnson & Johnson Oral Solid Dosage Medicine Introduction
11.1.4 Johnson & Johnson Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.1.5 Johnson & Johnson Recent Development
11.2 Novartis
11.2.1 Novartis Company Detail
11.2.2 Novartis Business Overview
11.2.3 Novartis Oral Solid Dosage Medicine Introduction
11.2.4 Novartis Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.2.5 Novartis Recent Development
11.3 Roche
11.3.1 Roche Company Detail
11.3.2 Roche Business Overview
11.3.3 Roche Oral Solid Dosage Medicine Introduction
11.3.4 Roche Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.3.5 Roche Recent Development
11.4 AbbVie
11.4.1 AbbVie Company Detail
11.4.2 AbbVie Business Overview
11.4.3 AbbVie Oral Solid Dosage Medicine Introduction
11.4.4 AbbVie Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.4.5 AbbVie Recent Development
11.5 Merck & Co.
11.5.1 Merck & Co. Company Detail
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Oral Solid Dosage Medicine Introduction
11.5.4 Merck & Co. Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.5.5 Merck & Co. Recent Development
11.6 Bristol Myers Squibb
11.6.1 Bristol Myers Squibb Company Detail
11.6.2 Bristol Myers Squibb Business Overview
11.6.3 Bristol Myers Squibb Oral Solid Dosage Medicine Introduction
11.6.4 Bristol Myers Squibb Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.6.5 Bristol Myers Squibb Recent Development
11.7 GlaxoSmithKline
11.7.1 GlaxoSmithKline Company Detail
11.7.2 GlaxoSmithKline Business Overview
11.7.3 GlaxoSmithKline Oral Solid Dosage Medicine Introduction
11.7.4 GlaxoSmithKline Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.7.5 GlaxoSmithKline Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Detail
11.8.2 Pfizer Business Overview
11.8.3 Pfizer Oral Solid Dosage Medicine Introduction
11.8.4 Pfizer Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.8.5 Pfizer Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Detail
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Oral Solid Dosage Medicine Introduction
11.9.4 Sanofi Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.9.5 Sanofi Recent Development
11.10 Takeda
11.10.1 Takeda Company Detail
11.10.2 Takeda Business Overview
11.10.3 Takeda Oral Solid Dosage Medicine Introduction
11.10.4 Takeda Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.10.5 Takeda Recent Development
11.11 AstraZeneca
11.11.1 AstraZeneca Company Detail
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Oral Solid Dosage Medicine Introduction
11.11.4 AstraZeneca Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.11.5 AstraZeneca Recent Development
11.12 Bayer
11.12.1 Bayer Company Detail
11.12.2 Bayer Business Overview
11.12.3 Bayer Oral Solid Dosage Medicine Introduction
11.12.4 Bayer Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.12.5 Bayer Recent Development
11.13 Eli Lilly & Co.
11.13.1 Eli Lilly & Co. Company Detail
11.13.2 Eli Lilly & Co. Business Overview
11.13.3 Eli Lilly & Co. Oral Solid Dosage Medicine Introduction
11.13.4 Eli Lilly & Co. Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.13.5 Eli Lilly & Co. Recent Development
11.14 Gilead Sciences
11.14.1 Gilead Sciences Company Detail
11.14.2 Gilead Sciences Business Overview
11.14.3 Gilead Sciences Oral Solid Dosage Medicine Introduction
11.14.4 Gilead Sciences Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.14.5 Gilead Sciences Recent Development
11.15 Amgen
11.15.1 Amgen Company Detail
11.15.2 Amgen Business Overview
11.15.3 Amgen Oral Solid Dosage Medicine Introduction
11.15.4 Amgen Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.15.5 Amgen Recent Development
11.16 Novo Nordisk
11.16.1 Novo Nordisk Company Detail
11.16.2 Novo Nordisk Business Overview
11.16.3 Novo Nordisk Oral Solid Dosage Medicine Introduction
11.16.4 Novo Nordisk Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.16.5 Novo Nordisk Recent Development
11.17 Teva
11.17.1 Teva Company Detail
11.17.2 Teva Business Overview
11.17.3 Teva Oral Solid Dosage Medicine Introduction
11.17.4 Teva Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.17.5 Teva Recent Development
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Detail
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Oral Solid Dosage Medicine Introduction
11.18.4 Boehringer Ingelheim Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.18.5 Boehringer Ingelheim Recent Development
11.19 Biogen
11.19.1 Biogen Company Detail
11.19.2 Biogen Business Overview
11.19.3 Biogen Oral Solid Dosage Medicine Introduction
11.19.4 Biogen Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.19.5 Biogen Recent Development
11.20 Astellas
11.20.1 Astellas Company Detail
11.20.2 Astellas Business Overview
11.20.3 Astellas Oral Solid Dosage Medicine Introduction
11.20.4 Astellas Revenue in Oral Solid Dosage Medicine Business (2018-2024)
11.20.5 Astellas Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Oral Solid Dosage Medicine Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
Table 2. Key Players of Brands Drugs
Table 3. Key Players of Generic Drugs
Table 4. Global Oral Solid Dosage Medicine Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
Table 5. Global Oral Solid Dosage Medicine Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Oral Solid Dosage Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Oral Solid Dosage Medicine Market Share by Region (2018-2024)
Table 8. Global Oral Solid Dosage Medicine Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Oral Solid Dosage Medicine Market Share by Region (2024-2029)
Table 10. Oral Solid Dosage Medicine Market Trends
Table 11. Oral Solid Dosage Medicine Market Drivers
Table 12. Oral Solid Dosage Medicine Market Challenges
Table 13. Oral Solid Dosage Medicine Market Restraints
Table 14. Global Oral Solid Dosage Medicine Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Oral Solid Dosage Medicine Market Share by Players (2018-2024)
Table 16. Global Top Oral Solid Dosage Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Medicine as of 2022)
Table 17. Ranking of Global Top Oral Solid Dosage Medicine Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Oral Solid Dosage Medicine Revenue (CR5 and HHI) & (2018-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oral Solid Dosage Medicine Product Solution and Service
Table 21. Date of Enter into Oral Solid Dosage Medicine Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oral Solid Dosage Medicine Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Oral Solid Dosage Medicine Revenue Market Share by Type (2018-2024)
Table 25. Global Oral Solid Dosage Medicine Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Oral Solid Dosage Medicine Revenue Market Share by Type (2024-2029)
Table 27. Global Oral Solid Dosage Medicine Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Oral Solid Dosage Medicine Revenue Market Share by Application (2018-2024)
Table 29. Global Oral Solid Dosage Medicine Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Oral Solid Dosage Medicine Revenue Market Share by Application (2024-2029)
Table 31. North America Oral Solid Dosage Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 32. North America Oral Solid Dosage Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 33. North America Oral Solid Dosage Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 34. Europe Oral Solid Dosage Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 35. Europe Oral Solid Dosage Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 36. Europe Oral Solid Dosage Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 37. Asia-Pacific Oral Solid Dosage Medicine Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
Table 38. Asia-Pacific Oral Solid Dosage Medicine Market Size by Region (2018-2024) & (US$ Million)
Table 39. Asia-Pacific Oral Solid Dosage Medicine Market Size by Region (2024-2029) & (US$ Million)
Table 40. Latin America Oral Solid Dosage Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 41. Latin America Oral Solid Dosage Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 42. Latin America Oral Solid Dosage Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 43. Middle East & Africa Oral Solid Dosage Medicine Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
Table 44. Middle East & Africa Oral Solid Dosage Medicine Market Size by Country (2018-2024) & (US$ Million)
Table 45. Middle East & Africa Oral Solid Dosage Medicine Market Size by Country (2024-2029) & (US$ Million)
Table 46. Johnson & Johnson Company Detail
Table 47. Johnson & Johnson Business Overview
Table 48. Johnson & Johnson Oral Solid Dosage Medicine Product
Table 49. Johnson & Johnson Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 50. Johnson & Johnson Recent Development
Table 51. Novartis Company Detail
Table 52. Novartis Business Overview
Table 53. Novartis Oral Solid Dosage Medicine Product
Table 54. Novartis Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 55. Novartis Recent Development
Table 56. Roche Company Detail
Table 57. Roche Business Overview
Table 58. Roche Oral Solid Dosage Medicine Product
Table 59. Roche Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 60. Roche Recent Development
Table 61. AbbVie Company Detail
Table 62. AbbVie Business Overview
Table 63. AbbVie Oral Solid Dosage Medicine Product
Table 64. AbbVie Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Merck & Co. Company Detail
Table 67. Merck & Co. Business Overview
Table 68. Merck & Co. Oral Solid Dosage Medicine Product
Table 69. Merck & Co. Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 70. Merck & Co. Recent Development
Table 71. Bristol Myers Squibb Company Detail
Table 72. Bristol Myers Squibb Business Overview
Table 73. Bristol Myers Squibb Oral Solid Dosage Medicine Product
Table 74. Bristol Myers Squibb Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 75. Bristol Myers Squibb Recent Development
Table 76. GlaxoSmithKline Company Detail
Table 77. GlaxoSmithKline Business Overview
Table 78. GlaxoSmithKline Oral Solid Dosage Medicine Product
Table 79. GlaxoSmithKline Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 80. GlaxoSmithKline Recent Development
Table 81. Pfizer Company Detail
Table 82. Pfizer Business Overview
Table 83. Pfizer Oral Solid Dosage Medicine Product
Table 84. Pfizer Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 85. Pfizer Recent Development
Table 86. Sanofi Company Detail
Table 87. Sanofi Business Overview
Table 88. Sanofi Oral Solid Dosage Medicine Product
Table 89. Sanofi Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 90. Sanofi Recent Development
Table 91. Takeda Company Detail
Table 92. Takeda Business Overview
Table 93. Takeda Oral Solid Dosage Medicine Product
Table 94. Takeda Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 95. Takeda Recent Development
Table 96. AstraZeneca Company Detail
Table 97. AstraZeneca Business Overview
Table 98. AstraZeneca Oral Solid Dosage Medicine Product
Table 99. AstraZeneca Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 100. AstraZeneca Recent Development
Table 101. Bayer Company Detail
Table 102. Bayer Business Overview
Table 103. Bayer Oral Solid Dosage Medicine Product
Table 104. Bayer Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 105. Bayer Recent Development
Table 106. Eli Lilly & Co. Company Detail
Table 107. Eli Lilly & Co. Business Overview
Table 108. Eli Lilly & Co. Oral Solid Dosage Medicine Product
Table 109. Eli Lilly & Co. Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 110. Eli Lilly & Co. Recent Development
Table 111. Gilead Sciences Company Detail
Table 112. Gilead Sciences Business Overview
Table 113. Gilead Sciences Oral Solid Dosage Medicine Product
Table 114. Gilead Sciences Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 115. Gilead Sciences Recent Development
Table 116. Amgen Company Detail
Table 117. Amgen Business Overview
Table 118. Amgen Oral Solid Dosage Medicine Product
Table 119. Amgen Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 120. Amgen Recent Development
Table 121. Novo Nordisk Company Detail
Table 122. Novo Nordisk Business Overview
Table 123. Novo Nordisk Oral Solid Dosage Medicine Product
Table 124. Novo Nordisk Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 125. Novo Nordisk Recent Development
Table 126. Teva Company Detail
Table 127. Teva Business Overview
Table 128. Teva Oral Solid Dosage Medicine Product
Table 129. Teva Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 130. Teva Recent Development
Table 131. Boehringer Ingelheim Company Detail
Table 132. Boehringer Ingelheim Business Overview
Table 133. Boehringer Ingelheim Oral Solid Dosage Medicine Product
Table 134. Boehringer Ingelheim Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 135. Boehringer Ingelheim Recent Development
Table 136. Biogen Company Detail
Table 137. Biogen Business Overview
Table 138. Biogen Oral Solid Dosage Medicine Product
Table 139. Biogen Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 140. Biogen Recent Development
Table 141. Astellas Company Detail
Table 142. Astellas Business Overview
Table 143. Astellas Oral Solid Dosage Medicine Product
Table 144. Astellas Revenue in Oral Solid Dosage Medicine Business (2018-2024) & (US$ Million)
Table 145. Astellas Recent Development
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oral Solid Dosage Medicine Market Size Comparison by Type (2024-2029) & (US$ Million)
Figure 2. Global Oral Solid Dosage Medicine Market Share by Type: 2022 VS 2029
Figure 3. Brands Drugs Features
Figure 4. Generic Drugs Features
Figure 5. Global Oral Solid Dosage Medicine Market Size Comparison by Application (2024-2029) & (US$ Million)
Figure 6. Global Oral Solid Dosage Medicine Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Oral Solid Dosage Medicine Report Years Considered
Figure 10. Global Oral Solid Dosage Medicine Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 11. Global Oral Solid Dosage Medicine Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Oral Solid Dosage Medicine Market Share by Region: 2022 VS 2029
Figure 13. Global Oral Solid Dosage Medicine Market Share by Players in 2022
Figure 14. Global Top Oral Solid Dosage Medicine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oral Solid Dosage Medicine as of 2022)
Figure 15. The Top 10 and 5 Players Market Share by Oral Solid Dosage Medicine Revenue in 2022
Figure 16. North America Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 17. North America Oral Solid Dosage Medicine Market Share by Country (2018-2029)
Figure 18. United States Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 19. Canada Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 20. Europe Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 21. Europe Oral Solid Dosage Medicine Market Share by Country (2018-2029)
Figure 22. Germany Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. France Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 24. U.K. Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 25. Italy Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 26. Russia Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 27. Nordic Countries Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. Asia-Pacific Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. Asia-Pacific Oral Solid Dosage Medicine Market Share by Region (2018-2029)
Figure 30. China Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Japan Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. South Korea Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. Southeast Asia Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 34. India Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 35. Australia Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 36. Latin America Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 37. Latin America Oral Solid Dosage Medicine Market Share by Country (2018-2029)
Figure 38. Mexico Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 39. Brazil Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 40. Middle East & Africa Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. Middle East & Africa Oral Solid Dosage Medicine Market Share by Country (2018-2029)
Figure 42. Turkey Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Saudi Arabia Oral Solid Dosage Medicine Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. Johnson & Johnson Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 45. Novartis Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 46. Roche Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 47. AbbVie Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 48. Merck & Co. Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 49. Bristol Myers Squibb Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 50. GlaxoSmithKline Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 51. Pfizer Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 52. Sanofi Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 53. Takeda Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 54. AstraZeneca Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 55. Bayer Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 56. Eli Lilly & Co. Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 57. Gilead Sciences Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 58. Amgen Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 59. Novo Nordisk Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 60. Teva Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 61. Boehringer Ingelheim Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 62. Biogen Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 63. Astellas Revenue Growth Rate in Oral Solid Dosage Medicine Business (2018-2024)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries